Trial intelligence / Profile preview

SLT vs. Travoprost on Circadian IOP

NCT02105311Phase 4Completed

Sponsor
Prince of Songkla University
Start
Mar 2014
Primary completion
Feb 2016
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 4 trial of travoprost in Open-angle glaucoma (OAG), Normal tension glaucoma (NTG), ocular hypertension, sponsored by Prince of Songkla University. Started Mar 2014; status: completed.

02

Drugs

travoprost
03

Conditions

Open-angle glaucoma (OAG)Normal tension glaucoma (NTG)ocular hypertension

Beyond the preview

Go deeper on NCT02105311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02105311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call